(Hypertension. 2001;38:261.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Université de Montréal, Departemént de Physiologie, et lInstitut de Cardiologie de Montréal, Montréal, Québec, Canada.
Correspondence to Angelino Calderone, lInstitut de Cardiologie de Montréal, 5000 rue Belanger est, Montréal, Québec, Canada H1T 1C8. E-mail calderon{at}icm.umontreal.ca
Abstract Transforming growth factor-ß (TGF-ß) has been implicated in the development of interstitial fibrosis in cardiac hypertrophy. NO has been regarded as a potent inhibitor of cardiac fibroblast growth, albeit the modulation of cellular events associated with interstitial fibrosis remains undefined. In this regard, the regulation of TGF-ß mRNA expression by the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) was examined in neonatal rat cardiac fibroblasts. SNAP treatment for 4 hours decreased TGF-ß3 mRNA levels, an effect mimicked by 8-bromo-cGMP. TGF-ß3 mRNA, however, had returned to levels observed in the untreated cells after a 24-hour exposure to SNAP, whereas a decreased expression persisted with 8-bromo-cGMP. In contrast to TGF-ß3, TGF-ß1 mRNA levels were modestly increased in response to cGMP-generating molecules. The treatment with actinomycin D for at least 8 hours did not appreciably alter TGF-ß3 mRNA levels. By contrast, SNAP treatment caused a rapid decrease of TGF-ß3 mRNA with a half-life of 3.3±0.2 hours, thereby supporting a mechanism of destabilization. The pretreatment with SNAP inhibited angiotensin II-stimulated protein synthesis and the concomitant expression of TGF-ß3 mRNA. These data reveal a disparate pattern of TGF-ß1 and TGF-ß3 mRNA regulation by NO and highlight a novel mechanism of destabilization contributing to the decreased expression of TGF-ß3 mRNA. The modulation of both basal and angiotensin II-stimulated TGF-ß3 mRNA expression provides a mechanism by which NO may influence the progression of interstitial fibrosis.
Key Words: nitric oxide cyclic GMP fibroblasts RNA, messenger transforming growth factors angiotensin II
This article has been cited by other articles:
![]() |
R. Schreckenberg, S. Wenzel, R. M. da Costa Rebelo, A. Rothig, R. Meyer, and K.-D. Schluter Cell-Specific Effects of Nitric Oxide Deficiency on Parathyroid Hormone-Related Peptide (PTHrP) Responsiveness and PTH1 Receptor Expression in Cardiovascular Cells Endocrinology, August 1, 2009; 150(8): 3735 - 3741. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, D. Wang, J. Lucas, S. Oparil, D. Xing, X. Cao, L. Novak, M. B. Renfrow, and Y.-F. Chen Atrial Natriuretic Peptide Inhibits Transforming Growth Factor {beta}-Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts Circ. Res., February 1, 2008; 102(2): 185 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, J. Zhang, S. Theel, J. J. Barb, P. J. Munson, and R. L. Danner Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elements Nucleic Acids Res., June 6, 2006; 34(10): 3044 - 3056. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Pilz and D. E. Casteel Regulation of Gene Expression by Cyclic GMP Circ. Res., November 28, 2003; 93(11): 1034 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, W. Eberhardt, and A. Huwiler Nitric Oxide and Mechanisms of Redox Signaling J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S237 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-S. Akool, H. Kleinert, F. M. A. Hamada, M. H. Abdelwahab, U. Forstermann, J. Pfeilschifter, and W. Eberhardt Nitric Oxide Increases the Decay of Matrix Metalloproteinase 9 mRNA by Inhibiting the Expression of mRNA-Stabilizing Factor HuR Mol. Cell. Biol., July 15, 2003; 23(14): 4901 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. Wang, R. Yuan, Y.-P. Sun, T.-J. Lee, and G. V. Shah Antiproliferative Action of Calcitonin on Lactotrophs of the Rat Anterior Pituitary Gland: Evidence for the Involvement of Transforming Growth Factor {beta}1 in Calcitonin Action Endocrinology, May 1, 2003; 144(5): 2164 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Eberhardt, E.-S. Akool, J. Rebhan, S. Frank, K.-F. Beck, R. Franzen, F. M. A. Hamada, and J. Pfeilschifter Inhibition of Cytokine-induced Matrix Metalloproteinase 9 Expression by Peroxisome Proliferator-activated Receptor alpha Agonists Is Indirect and Due to a NO-mediated Reduction of mRNA Stability J. Biol. Chem., August 30, 2002; 277(36): 33518 - 33528. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |